Vol. 25 • Na. N1 • February 2023

In this issue:

• The assessment of blood homocysteine and S100B levels in patients with opioid use disorders
  Yıldırım Ozbek S., Inanlı İ., Eren I., Cicek E., Ozbek S., Kurku H., Demirel B., Cicek İ.E., and Uygur H.
• Previously Used Substances and Predictors of Illicit Drug Use among Incarcerated Male Prisoners in Galle, Sri Lanka
  Darshana N., Ruben R., and Wijesinghe C.
• Neonatal Abstinence Syndrome in Vojvodina, Serbia: Infant and Maternal Characteristics
  Mijatović Jovin V., Vejnović A., Knezović G., Pavlović V., Vejnović A.-M., and Dickov I.
• The role of biopsychological factors in relapse of patients undergoing Methadone Maintenance Treatment in Iran
  Motazedian S., Kheradmand A., Badiei R., Seif P., and Danesh A.
• Artistic clues to the diagnosis of bipolar dual disorder in opioid addicts. The case of Nachtmystium
  Pacini M., and Maremmani I.

Vol. 25 • Na. N2 • April 2023

In this issue:

• The effect of Raha syrup on the development of morphine tolerance and dependence on rats
  Haerifar F., Zahedi-Khorasani M., Ghanbari A., and Miladi-Gorji H.
• The impact of COVID-19 pandemic on pregnant women with Substance Use Disorder (SUD): a narrative review
  Caglioni M., Ragona A., Maremmani A.G.I., Silvia C., and Cerniglia L.
• Maternal Methadone Split Dosing in Pregnancy
  Flores C., and Riaz U.
• CYP genetic polymorphism, pharmacokinetics of methadone, and the biggest risks
  Jovanovic M., Bozovic N., Rancic N., Pjevac A., Rascanin S., and Stojkovic M.
• Insight in dual disorder heroin addicts. Are they able to request adequate treatment?
  Pacini M., Maremmani A.G.I., Della Rocca F., Miccoli M., and Maremmani I.

Vol. 25 • Na. N3 • June 2023

In this issue:

• Positive Psychology as a Protective Factor for Illicit Opioids in Individuals Receiving Methadone Treatment.
  Krembuszewski B., Anderson-White E., Henderson C., White S., and Langley H.
• Effect of Raha Syrup on the Severity of Dependence, Depression, Anxiety, Stress, Craving and Serum Serotonin Levels in Patients with Opioid Use Disorder Receiving the Opium Tincture Maintenance Treatment
  Shokravian M., Miladi-Gorji H., Shajiee H., Ghorbani R., and Mazinani M.
• Telemedicine in Addictions: Feasibility Randomised Controlled Trial
  Mayet S., Gledhill A., McCaw I., Hashmani Z., Drozdova Z., Arshad S., Shahbaz S., Huang C., and Phillips T.
• Cocaine Use in Opioid and Alcohol Substance Use Disorders
  Pacini M., Della Rocca F., Maremmani A.G.I., and Maremmani I.

Vol. 25 • Na. N4 • August 2023

In this issue:

• Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway
  Weimand B., Karlsson A.T., Solli K.K., Vederhus J.-K., Mordal J., Wergeland Digranes L., and Tanum L.
• Evaluating α-synuclein, dopamine and serotonin concentrations in the blood of patients with heroin use disorder: Baseline and post-treatment comparisons
  Yazla E., Cetin I., and Kayadibi H.
• Exposure and addiction rates to substances and behaviours among Israeli university students
  Snits A., Rozner L., Shoshan S., and Peles E.
• Differences in the time needed for solid versus liquid delivery of methadone for patients with Opioid Use Disorder in Italy: The SO.LI.D.O 2 study
  Bruno G.M., Caruggi M., Ciccarone A., Valentino M.C., Ariano V., De Fazio S., Leonardi C., Ventre G., Riglietta M., Somaini L., Corbetta Andrea for the SO.LI.D.O. 2 Group, and Colombo G.L.
• Trends of hospital admissions for alcohol, cannabinoids, benzodiazepines and heroin-related intoxications among children, adolescents and young adults in Slovenia in the years 1999–2019 and the possible impact of economic crisis
  Lovrecic B., Lovrecic M., Simon M.R., Korosec A., Stibernik M., and Maremmani A.G.I.

Vol. 25 • Na. N5 • October 2023

In this issue:

• An uncontrolled pilot trial of a buprenorphine dispensing device to enhance outpatient treatment for opioid use disorder
  Wenzel K., Thomas J., Davis M., Saenko M., Ervin M., Machineni P., Rudin L., and Fishman M.
• Electrocardiogram and Liver Function Changes in Methadone Maintenance Treatment After Heroin Use
  Hu H., Lu D., Xie R., Zhong S., Cao S., and Liu L.
• Predictors of relapse following institutional drug rehabilitation among male drug addicts in selected rehabilitation centres in Sri Lanka – A nested case-control study
  Darshana N., Wijesinghe C., and De Silva V.
• The role of economic, social and occupational factors in relapse among patients with methadone maintenance treatment (MMT): A descriptive-analytical study
  Motazedian S., Kheradmand A., Badiei R., Babazadehdezfoly A., and Keshavarzi A.
• Is mothers' cocaine use associated with poorer quality of feeding interactions with their offspring?
  Cerniglia L., Maremmani A.G.I., and Cimino S.

Vol. 25 • Na. N6 • December 2023

In this issue:

• Prevalence of Attention Deficit Hyperactivity Disorder in Adults Individuals with Addiction Disorders
  Auriemma F., Direnzo G.F.M., Pero D., Boccassi L., Carbone V., Cefalo G., Cervelli C., Colurcio B., Costrini P., Cortese E., Davide C., Forino G., Garofano R., Maione F., Marguccio E., Navarra A., Nunzi M., Pirrotta F., Pizzirusso A., Scarpino V., Tulino
• Patients on buprenorphine maintenance treatment. Cannabis and amphetamine use
  Simonovska N., Velikj Stefanovska V., Bekarovski N., Petkovska L., Pereska Z., Babulovska A., and Kostovski D.
• Are urine tests within opioid agonist treatment a justified practice?
  Baud C.-A., Schmitt-Koopmann C., Junod V., Dickson C., Brülisauer L., Broers B., and Simon O.
• Comparing the Effectiveness of Emotion-focused Therapy and Schema Therapy in Impulsivity, Shame, and Self-blame in Addicts on Methadone Maintenance Treatment: A Clinical Trial Study
  Salasi B., Ramezani M.A., Jahan F., and Kordbagheri M.
• Addressing Illicit Drug Use and Mental Health in Prisons: Insights and Recommendations from International Studies
  Wei L.